TrialAnnals of the rheumatic diseases2021

Efficacy and safety of abatacept in active primary Sjögren's syndrome: results of a phase III, randomised, placebo-controlled trial.

Alan N Baer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.